Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Corplex Donepezil TDS vs Oral Aricept
NCT02968719Phase 1Completed
- Sponsor
- Corium
- Start
- Nov 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of donepezil in Alzheimer's disease (AD) (3 arms), sponsored by Corium. Primary endpoints: Steady-state Pharmacokinetics at Day 54 and Pharmacokinetics (Part B) at Day 36. Started Nov 2016; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02968719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02968719.